20-F XBRL

FORM 20-F

Company: Galmed Pharmaceuticals Ltd.
Filed: March 13, 2019
Period of Report: December 31, 2018
Accession Number: 0001144204-19-013601

View Document ↗ View on SEC.gov ↗